Trial Profile
Randomised controlled trial of etanercept and methotrexate in very early rheumatoid arthritis with sustained remission after etanercept withdrawal.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 22 Jan 2011
Price :
$35
*
At a glance
- Drugs Etanercept (Primary) ; Methotrexate (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 17 Jan 2011 Actual end date (31 Dec 2010) added as reported by ISRCTN: Current Controlled Trials.
- 17 Jan 2011 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
- 10 Nov 2010 New source identified and integrated (ISRCTN: Current Controlled Trials.).